Thread embedding acupuncture in postmenopausal women with overactive bladder

Effectiveness and Safety of Thread Embedding Acupuncture in Postmenopausal Women with Overactive Bladder

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0009905

Enrollment

Registered

2024-11-07

Start date

2024-01-09

Completion date

Unknown

Last updated

2024-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : -Thread Embedding Acupuncture: The treatment group received thread embedding acupuncture with disposable needles (30G x 25mm) at specified acupoints including CV3 (Zhongji), BL33 (Zho

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: (1) age >40 years and not pregnant; (2) amenorrhea for =1 year and no history of hormone replacement therapy in the preceding 6 months; (3) frequent and urgent urination lasting for >3 months; (4) meeting the diagnostic criteria for OAB with a total score of =3 on the Korean version of the overactive bladder symptom score (OABSS)17; (5) urinary urgency as defined by the urgency rating scale (URS) as =2 points and an average urinary frequency of =8 times/day and/or UUI, according to a 3-day bladder diary, over a 1-week screening period; (6) agreement with study protocols after sufficient explanation.

Exclusion criteria

Exclusion criteria: (1) urinary tract infection upon urine examination; (2) stress urinary incontinence without OAB symptoms; (3) suspected urinary dysfunction due to neurological damage; (4) history of cystocele, uterine prolapse, or similar diseases; (5) history of obstructive uropathy conditions, such as urolithiasis or urinary tract tumours; (6) history of surgery on the urethra or bladder; (7) history of urinary tract malignancy; (8) history of neurological or psychiatric diseases; (9) presence of artificial pacemaker or implantable cardioverter-defibrillator in the chest; (10) experience of hypersensitivity or any other side effect after acupuncture treatment; (11) involvement in any other clinical trial in the preceding 3 months; (12) taking a drug that may affect bladder function within 1 month before trial commencement; (13) insufficient literacy to complete study documents.

Design outcomes

Primary

Measure	Time frame
average number of micturitions per 24hour	—

Secondary

Measure	Time frame
average number of micturitions per 24 hour, daytime micturitions, nocturnal micturitions;average number of total urgency and urgent urinary incontinence;the Overactive bladder symptom score;the Korean version of King's health questionnaire score	—

Countries

Korea, Republic of

Contacts

Public ContactSu-Ji Choi

Dong-Eui University Oriental Medicine Hospital

cindy5333@deu.ac.kr+82-51-850-8660

Outcome results